SPRC News

SciSparc: Subsidiary NeuroThera Labs Advances its Quantum Platform for Clinical Data Analytics on a Platform of an S&P 500 company

SciSparc Announces Decision to Target the Agentic AI Market; Forms Scientific Advisory Board for Artificial Intelligence and Cybersecurity

SciSparc: NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome

Americore Resources Appoints Justin Hanka to Board of Directors Ready to Announce with Confidence?

P3 Media Launches Forward Deployed Engineering Practice to Help Commerce Brands Adopt, Deploy, and Scale AI

SciSparc: Subsidiary NeuroThera Labs Completed Acquisition of CliniQuantum

Acronis Announces New #TeamUp Partnership with University of Georgia Athletic Association, Delivered by Sourcepass Liberty

Park Systems lanza Park FX40 IR, que combina el rendimiento de AFM y la espectroscopia IR a nanoescala USA - español USA - English USA - English USA - Français USA - Deutsch

SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum

Sapu Nano Announces First Patient Dosed in Phase 1b Trial of Sapu003, an Intravenous Deciparticle™ Formulation of Everolimus